RENVA covers weight loss / glp-1 telehealth providers with independent pricing research and comparison guides. All affiliate relationships are disclosed. No medical advice.
Most recently published article in this library.
GLP-1 medications explained in plain language: what they are, how they work in your gut and brain, which drugs are FDA-approved for weight loss, and what clinical trials found.
GLP-1 medications start affecting appetite within days, but meaningful weight loss builds over months. Here's the actual week-by-week timeline from clinical trial data.
The FDA-approved titration schedules for Wegovy, Zepbound, and Foundayo explained — plus why skipping steps or 'microdosing' claims deviate from tested, approved dosing.
Foundayo is a once-daily GLP-1 pill with no fasting rules — a different molecule type from semaglutide. Here's how it works, what the trials found, and how it compares.
Tirzepatide activates one more hormone receptor than semaglutide — and across every major trial, that difference shows up as more average weight loss.
Wegovy and Ozempic both contain semaglutide — but they're approved for different uses, dosed differently, and covered differently by insurance.
The two FDA-approved weekly weight-loss injections compared on mechanism, trial results, cardiovascular approval, and available formulations.
Oral GLP-1 pills have closed much of the gap with weekly injections. Here's how the two approaches compare on results, convenience, and what the trial data actually shows.
GLP-1 insurance coverage varies enormously by plan type. Here's what commercial insurance, Medicare, and Medicaid actually cover in 2026, plus options if you're uninsured.
The Medicare GLP-1 Bridge offers eligible beneficiaries GLP-1 medications for $50/month starting July 2026. Here's exactly who qualifies, what's covered, and how it works.
A clear look at GLP-1 side effects — from common nausea to rare but serious risks — based on FDA labeling and adverse event data, plus what tends to help.
GLP-1 weight loss isn't all fat — research shows 20–40% can be lean muscle. Here's what the science says about why, and how nutrition and exercise can help protect it.
Research on stopping GLP-1 medications like semaglutide and tirzepatide shows most people regain a significant share of lost weight. Here's what the data actually shows.
The FDA doesn't require specific labs before starting a GLP-1 medication, but clinical guidelines recommend a standard set. Here's what's typically tested and why.
What it actually takes to get prescribed Wegovy, Zepbound, or another GLP-1 medication — eligibility criteria, the evaluation process, insurance steps, and realistic timelines.
A complete breakdown of who qualifies for GLP-1 weight-loss medications, who doesn't, and the specific contraindications and special-population considerations behind the FDA criteria.
A complete checklist of questions to ask any GLP-1 provider before you start — medication, clinical oversight, cost, and program quality — so nothing catches you off guard.
Compounded GLP-1 medications aren't FDA-approved and aren't reviewed for safety or quality before they're sold. Here's what that actually means and why the distinction matters.
If a provider prescribes compounded GLP-1 medication, here's exactly how to check whether the pharmacy is properly licensed and registered — 503A, 503B, and LegitScript explained.
Affiliate disclosure: RENVA may earn affiliate commissions from some provider links. Affiliate relationships do not influence provider scoring or editorial conclusions. Full disclosure →
Medical disclaimer: RENVA is not a healthcare provider. Content is informational and educational only. Always consult a licensed healthcare professional before making health decisions. Full disclaimer →